David Turkaly
Stock Analyst at JMP Securities
(2.21)
# 2,757
Out of 4,944 analysts
139
Total ratings
40%
Success rate
-3.83%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Market Outperform | $50 → $35 | $20.09 | +74.22% | 11 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $53.79 | +35.71% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $14.11 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $62.79 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $53.88 | +85.60% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $247.07 | +13.33% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $14.12 | +77.05% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $29.59 | +85.87% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $103.22 | +21.10% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $432.12 | +15.71% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $378.95 | - | 3 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $122.92 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.47 | +377.82% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $14.76 | +76.15% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $15.70 | +103.82% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $7.32 | +118.58% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.36 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.87 | -22.48% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.80 | -43.15% | 1 | Oct 6, 2017 |
OrthoPediatrics
Aug 8, 2025
Maintains: Market Outperform
Price Target: $50 → $35
Current: $20.09
Upside: +74.22%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $53.79
Upside: +35.71%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.11
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $62.79
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $53.88
Upside: +85.60%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $247.07
Upside: +13.33%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $14.12
Upside: +77.05%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $29.59
Upside: +85.87%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $103.22
Upside: +21.10%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $432.12
Upside: +15.71%
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $378.95
Upside: -
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $122.92
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.47
Upside: +377.82%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $14.76
Upside: +76.15%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $15.70
Upside: +103.82%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $7.32
Upside: +118.58%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.36
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.87
Upside: -22.48%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.80
Upside: -43.15%